◆英語タイトル:Aquinox Pharmaceuticals Inc (AQXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7954
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company’s lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a regualting component of the PI3K pathway. Its discovery platform is based on the screening of a natural product library of compounds to identify potential SHIP1 activators. Aquinox undertakes clinical trials of several drugs for the treatment of chronic obstructive pulmonary disease, bladder pain syndrome interstitial cystitis, allergic asthma and atopic dermatitis, among others. The company has operations in Canada and the US. Aquinox is headquartered in Vancouver, British Columbia, Canada.
Aquinox Pharmaceuticals Inc (AQXP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Licensing Agreements 11
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Equity Offering 12
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 17
Aquinox Pharma Completes IPO For US$53 Million 18
Aquinox Pharmaceuticals Inc – Key Competitors 20
Aquinox Pharmaceuticals Inc – Key Employees 21
Aquinox Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 08, 2018: Aquinox Pharmaceuticals announces second quarter 2018 financial results 23
May 08, 2018: Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results 25
Mar 12, 2018: Aquinox Pharmaceuticals Announces Year End 2017 Financial Results 27
Aug 08, 2017: Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results 28
May 09, 2017: Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results 30
Mar 09, 2017: Aquinox Pharmaceuticals Announces Year End 2016 Financial Results 31
Corporate Communications 33
Mar 27, 2017: Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Tables
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 17
Aquinox Pharma Completes IPO For US$53 Million 18
Aquinox Pharmaceuticals Inc, Key Competitors 20
Aquinox Pharmaceuticals Inc, Key Employees 21
Aquinox Pharmaceuticals Inc, Other Locations 22
List of Figures
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8